Literature DB >> 4001886

Mortality in rheumatoid arthritis, particularly as regards drug use.

P Allebeck, Y Rodvall, E Allander.   

Abstract

239 persons with rheumatoid arthritis (RA), previously investigated in an epidemiological survey of RA in Stockholm, were monitored for 13 years with the aim of eliciting the cause(s) of the high mortality among persons with RA. All hospitalizations were identified through the in-patient register of Stockholm County. A study based on medical record information was performed on a group of 157 persons who had been hospitalized during the follow-up. Dead and surviving persons were compared with regard to characteristics at the start of the follow-up, drug use, and diseases other than RA during the follow-up. Male sex and high Steinbrocker functional grading were the factors most closely associated with an increased death risk. Neither drug use generally, nor use of any particular type of drug, contributory cause, the disease RA in itself--and particularly its severe forms--is the main cause of the high mortality among RA sufferers.

Entities:  

Mesh:

Year:  1985        PMID: 4001886     DOI: 10.3109/03009748509165491

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  2 in total

1.  Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study.

Authors:  John H Kempen; Ebenezer Daniel; James P Dunn; C Stephen Foster; Sapna Gangaputra; Asaf Hanish; Kathy J Helzlsouer; Douglas A Jabs; R Oktay Kaçmaz; Grace A Levy-Clarke; Teresa L Liesegang; Craig W Newcomb; Robert B Nussenblatt; Siddharth S Pujari; James T Rosenbaum; Eric B Suhler; Jennifer E Thorne
Journal:  BMJ       Date:  2009-07-03

2.  Oral glucocorticoid therapy and all-cause and cause-specific mortality in patients with rheumatoid arthritis: a retrospective cohort study.

Authors:  Mohammad Movahedi; Ruth Costello; Mark Lunt; Stephen Richard Pye; Jamie Christopher Sergeant; William Gregory Dixon
Journal:  Eur J Epidemiol       Date:  2016-06-02       Impact factor: 8.082

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.